{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "currency": "JPY", "regularMarketChangePercent": -3.4482758, "regularMarketPrice": 280.0, "exchange": "JPX", "shortName": "TMS CO LTD", "longName": "TMS Co., Ltd.", "messageBoardId": "finmb_251909072", "exchangeTimezoneName": "Asia/Tokyo", "exchangeTimezoneShortName": "JST", "gmtOffSetMilliseconds": 32400000, "market": "jp_market", "marketState": "PREPRE", "esgPopulated": false, "sharesOutstanding": 36574900, "fiftyDayAverage": 483.42, "fiftyDayAverageChange": -203.42001, "fiftyDayAverageChangePercent": -0.42079353, "twoHundredDayAverage": 598.72174, "twoHundredDayAverageChange": -318.72174, "twoHundredDayAverageChangePercent": -0.532337, "marketCap": 10629415936, "sourceInterval": 15, "exchangeDataDelayedBy": 20, "averageAnalystRating": "1.0 - Strong Buy", "tradeable": false, "cryptoTradeable": false, "firstTradeDateMilliseconds": 1669075200000, "priceHint": 2, "regularMarketChange": -10.0, "regularMarketTime": 1683872101, "regularMarketDayHigh": 291.0, "regularMarketDayRange": "279.0 - 291.0", "regularMarketDayLow": 279.0, "regularMarketVolume": 165900, "regularMarketPreviousClose": 290.0, "bid": 280.0, "ask": 281.0, "fullExchangeName": "Tokyo", "regularMarketOpen": 291.0, "averageDailyVolume3Month": 405984, "averageDailyVolume10Day": 743690, "fiftyTwoWeekLowChange": 2.0, "fiftyTwoWeekLowChangePercent": 0.007194245, "fiftyTwoWeekRange": "278.0 - 1188.0", "fiftyTwoWeekHighChange": -908.0, "fiftyTwoWeekHighChangePercent": -0.76430976, "fiftyTwoWeekLow": 278.0, "fiftyTwoWeekHigh": 1188.0, "trailingAnnualDividendRate": 0.0, "trailingPE": 9.213557, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": 30.39, "symbol": "4891.T"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "11th Floor, Keio Fuchu 1 Chome Building", "address2": "1-9 Fuchu-cho", "city": "Fuchu", "zip": "183-0055", "country": "Japan", "phone": "81 42 307 7480", "website": "https://www.tms-japan.co.jp", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "TMS Co., Ltd. engages in the research and development, manufacture, and sale of drug products, quasi-drugs, drug substances, medical devices, and medical commodities. The company is developing TMS-007, a stachybotrys microspora triprenyl phenol (SMTP) congener with prothrombolytic and anti-inflammatory/antioxidative activities, which has completed Phase 2a clinical trials for acute ischemic stroke treatment; and TMS-008, an SMTP congener with anti-inflammatory/antioxidative activities under nonclinical development for inflammatory complications, such as acute kidney injury and cancer cachexia. It is also developing TMS-009, a product candidate in preclinical development. The company was incorporated in 2005 and is headquartered in Fuchu, Japan.", "companyOfficers": [{"maxAge": 1, "name": "Mr. Takuro  Wakabayashi", "title": "Pres & Representative Director", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Go  Ito", "title": "CFO & Board Member", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Koji  Ohe", "title": "Gen. Counsel", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Noriaki  Inamura Ph.D.", "title": "Head of R&D and Board Member", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "maxAge": 86400}}], "error": null}}